The symptom: you can't quote the patient in the room
The pricing transparency problem shows up at the worst moment: a patient is ready to start semaglutide or tirzepatide, and you cannot tell them the cost because your Anazao agreement rates are not visible until you are onboarded in myAnazao — or because you are still waiting on account setup after the New User Request. You either guess, quote a padded number to be safe, or tell the patient you will follow up.
For owners running multi-compounder formularies, the opacity is worse. Anazao pricing lives in one agreement; other partners live in other agreements. Without a single catalog showing landed cost per line, building a predictable cash-pay GLP-1 program means working from estimates rather than numbers.